AllSquare Wealth Management’s AbbVie ABBV Stock Holding History

AllSquare Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$610K	Buy	2,636 +232	+10%	+$47.2K	0.32%	51
2025 Q2	$446K	Sell	2,404 -33	-1%	-$6.13K	0.25%	60
2025 Q1	$511K	Sell	2,437 -19	-0.8%	-$3.69K	0.3%	53
2024 Q4	$436K	Buy	2,456 +100	+4%	+$18.4K	0.25%	59
2024 Q3	$465K	Hold	2,356	–	–	0.26%	56
2024 Q2	$404K	Hold	2,356	–	–	0.24%	58
2024 Q1	$429K	Hold	2,356	–	–	0.25%	57
2023 Q4	$365K	Sell	2,356 -302	-11%	-$44K	0.22%	62
2023 Q3	$396K	Sell	2,658 -50	-2%	-$7.34K	0.26%	53
2023 Q2	$369K	Sell	2,708 -400	-13%	-$58.7K	0.24%	58
2023 Q1	$495K	Buy	3,108 +143	+5%	+$21.9K	0.32%	46
2022 Q4	$479K	Hold	2,965	–	–	0.33%	44
2022 Q3	$398K	Buy	2,965 +250	+9%	+$35.9K	0.29%	48
2022 Q2	$416K	Buy	2,715 +50	+2%	+$7.64K	0.28%	51
2022 Q1	$432K	Sell	2,665 -31	-1%	-$4.5K	0.26%	55
2021 Q4	$365K	Sell	2,696 -125	-4%	-$14.8K	0.21%	63
2021 Q3	$304K	Hold	2,821	–	–	0.18%	71
2021 Q2	$318K	Sell	2,821 -14	-0.5%	-$1.58K	0.19%	72
2021 Q1	$307K	Sell	2,835 -38	-1%	-$4.07K	0.19%	70
2020 Q4	$308K	Buy	2,873 +512	+22%	+$49.2K	0.21%	61
2020 Q3	$207K	Buy	2,361 +1,700	+257%	+$160K	0.15%	74
2020 Q2	$65K	Buy	661 +439	+198%	+$38.7K	0.05%	154
2020 Q1	$17K	Hold	222	–	–	0.01%	252
2019 Q4	$20K	Buy	222 +10	+5%	+$830	0.01%	261
2019 Q3	$16K	Sell	212 -338	-61%	-$23.2K	0.01%	275
2019 Q2	$40K	Hold	550	–	–	0.03%	211
2019 Q1	$44K	Sell	550 -800	-59%	-$65.4K	0.03%	205
2018 Q4	$124K	Sell	1,350 -300	-18%	-$26.4K	0.1%	95
2018 Q3	$156K	Sell	1,650 -269	-14%	-$25.5K	0.12%	94
2018 Q2	$178K	Sell	1,919 -82	-4%	-$8.01K	0.13%	83
2018 Q1	$189K	Hold	2,001	–	–	0.15%	77
2017 Q4	$194K	Sell	2,001 -16	-0.8%	-$1.51K	0.15%	76
2017 Q3	$179K	Sell	2,017 -54	-3%	-$4.11K	0.15%	73
2017 Q2	$150K	Sell	2,071 -33	-2%	-$2.22K	0.15%	46
2017 Q1	$137K	Buy	2,104 +454	+28%	+$28.5K	0.12%	78
2016 Q4	$103K	Hold	1,650	–	–	0.09%	92
2016 Q3	$104K	Hold	1,650	–	–	0.1%	83
2016 Q2	$102K	Sell	1,650 -50	-3%	-$3.05K	0.1%	78
2016 Q1	$97K	Hold	1,700	–	–	0.1%	80
2015 Q4	$101K	Buy	1,700 +350	+26%	+$20.2K	0.1%	79
2015 Q3	$73K	Hold	1,350	–	–	0.07%	95
2015 Q2	$91K	Hold	1,350	–	–	0.08%	89
2015 Q1	$79K	Hold	1,350	–	–	0.08%	97
2014 Q4	$88K	Buy	+1,350	New	+$85.1K	0.09%	87

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AllSquare Wealth Management's ABBV Position: Q3 2025 in Review

AllSquare Wealth Management increased its AbbVie (ABBV) stake by 9.7% in Q3 2025, buying an estimated $47.2K and bringing the position to 2,636 shares worth $610K. The position accounts for 0.32% of the portfolio, ranked #51.

AllSquare Wealth Management first reported a position in ABBV in Q4 2014 and has held it in 44 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

AllSquare Wealth Management held 2,636 shares of AbbVie worth $610K as of Q3 2025.
AllSquare Wealth Management bought 232 AbbVie shares in Q3 2025, an estimated $47.2K.
AbbVie made up 0.32% of AllSquare Wealth Management's portfolio in Q3 2025, its #51 holding.
AllSquare Wealth Management first reported a position in AbbVie in Q4 2014 and has held it in 44 quarters since.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on AllSquare Wealth Management's 13F filing for Q3 2025, filed 12 Jan 2026.